STI Combined to Valsalva Maneuver for the Diagnosis of Left Ventricular Dysfunction in COPD Exacerbations
STICOPD
a New and Non Invasive Method to Calculate STI ( Systolic Time Intervals) Combined to Valsalva Maneuver in Patient With Acute Exacerbation of COPD
1 other identifier
observational
189
1 country
1
Brief Summary
The aim of this investigation was to assess the value of Systolic Time Intervals (STIs) as a method of detecting Left Ventricular Dysfunction (LVD) in patients admitted to the emergency department for cute exacerbations of chronic obstructive pulmonary disease (AECOPD) and whether STIs measured under Valsalva manoeuver (VM) could improve the distinction between patients with LVD and those without LVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 7, 2015
CompletedFirst Posted
Study publicly available on registry
June 25, 2015
CompletedSeptember 14, 2020
September 1, 2020
1.7 years
May 7, 2015
September 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diagnosis of left ventricular dysfunction
Systolic time intervals measured at baseline and under Valsalva maneuver
during the first day admission in emergency department
Interventions
STI measurements at baseline and under Valsalva maneuver
Eligibility Criteria
It is a prospective study of patients visiting the emergency department of the hospital Fattouma Bourguiba Monastir with decompensated chronic obstructive pulmonary disease COPD
You may qualify if:
- Oxygen Saturation (SPO2) \<90%,
- Respiratory Rate \>25c/min,
- PaCO2 \> 6 kPa et pH\< 7.35.
You may not qualify if:
- Neurological distress and hemodynamic instability
- Confusion, agitation
- pneumothorax
- Non cooperative patients
- Refusal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Fattouma Bourguiba
Monastir, 5000, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SEMIR NOUIRA, Pr
Fattouma Bourguiba University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 7, 2015
First Posted
June 25, 2015
Study Start
April 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
September 14, 2020
Record last verified: 2020-09